Latest Articles
Gates Foundation To Invest $2.5b On Women’s Health Research, Development - Channels Television
Gates Foundation To Invest $2.5b On Women’s Health Research, Development Channels Television
Published: Aug. 5, 2025, 10:38 a.m.
UN Sustainable Development Goals Archives - Pharmafile
UN Sustainable Development Goals Archives Pharmafile
Published: July 29, 2025, 9:20 a.m.
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Insider Monkey
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program Insider Monkey
Published: July 10, 2025, 3:21 p.m.
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Yahoo
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program Yahoo
Published: July 10, 2025, 3:13 p.m.
Organon Halts Development of Endometriosis Drug OG-6219 After Mid-Stage Trial Failure - geneonline.com
Organon Halts Development of Endometriosis Drug OG-6219 After Mid-Stage Trial Failure geneonline.com
Published: July 10, 2025, 8:10 a.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MSN
Organon to halt development of endometriosis pain drug after mid-stage trial failure MSN
Published: July 3, 2025, 10:49 p.m.
Organon abandons endometriosis pain drug development after trial failure - MSN
Organon abandons endometriosis pain drug development after trial failure MSN
Published: July 3, 2025, 4:01 p.m.
Organon drops OG-6219 development following trial miss - The Pharma Letter
Organon drops OG-6219 development following trial miss The Pharma Letter
Published: July 3, 2025, 10:55 a.m.
Karolinska Development receives update from Organon concerning OG-6219 - The Manila Times
Karolinska Development receives update from Organon concerning OG-6219 The Manila Times
Published: July 3, 2025, 5:03 a.m.
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial - Femtech Insider
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial Femtech Insider
Published: July 2, 2025, 9:17 p.m.
Link copied to clipboard!